− counterparts, whereas both subsets have similar IFN-γ responses. We further demonstrate that the CD16-dependent degranulation pathway, but not antibody-dependent cell-mediated cytotoxicity, contribute to the superior cytotoxicity of CD56 + Vγ9Vδ2 T cells. Our study provides further evidence for the phenotypic and functional characterization of human Vγ9Vδ2 T-cell subsets during fluA virus infection and may help improve the γδ T-cell-based immunotherapy for viral infection.
It has become increasingly clear that γδ T cells are important components in both innate and adaptive immune systems, yet the cellular requirement for the activation of γδ T cells is still poorly defined. Like αβ T cells, human Vγ9Vδ2 T cells can be divided into 4 subsets: naive, central memory, effector memory, and terminal differentiated cells, according to their surface expression of CD45RA and CD27 [1] [2] [3] [4] − ) Vγ9Vδ2 T cells prefer to locate at the inflammatory sites and can exhibit immediate effector functions [5] . Distinct memory phenotypes of γδ T cells may exhibit differential functions [5] [6] [7] and be associated with some diseases such as pulmonary tuberculosis [8] . For influenza A (fluA) virus infection, the differentiation of γδ T cells and their functions remain unclear.
CD56, a calcium-independent neural cell adhesion molecule [9] , is a signature marker for natural killer (NK) cells and has also been identified on other cells such as cytotoxic αβ T cells and γδ T cells [10] . The expression of CD56 on cytotoxic lymphocytes is usually associated with lack of major histocompatibility complex (MHC) restriction and reduced T cell receptor dependence [11] . However, little is known about the functions of CD56 + and CD56 − γδ T-cell subsets in fluA virus infection.
In our previous studies, we demonstrated that human Vγ9Vδ2 T cells are potent killers of fluA virus-infected cells and that γδ T-cell-based immunotherapy is an alternative for treating fluA infection [12] [13] [14] . In this study, we further evaluate different subsets of isopentenyl pyrophosphate (IPP)-expanded Vγ9Vδ2 T cells according to their memory types (CD27 expression or CD56 expression) and compare their functions in response to fluA viruses.
MATERIALS AND METHODS

Cells
Peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats of healthy donors (from Hong Kong Red Cross) by Ficoll-Hypaque (Pharmacia) gradient centrifugation. The research protocol was approved by the Institutional Review Board of the University of Hong Kong. The IPPexpanded Vγ9Vδ2 T cells were generated as described elsewhere [12] . Briefly, PBMCs were cultured in Roswell Park Memorial Institute 1640 medium supplemented with 10% fetal bovine serum. IPP (Sigma) was added at days 0 and 3 to a final concentration of 6 μg/mL. Recombinant human interleukin 2 (IL-2) (Invitrogen) was added to a final concentration of 500 IU/mL every 3 days starting on day 3. After 14 days of culture, the cells were purified by negative selection with a TCR γ/δ + T-cell isolation kit according to manufacturer's instructions (Miltenyi Biotec). The purity of γδ T cells, as determined by flow cytometry with anti-CD3 and anti-Vδ2 monoclonal antibodies (mAbs), was consistently >98%. Human monocyte-derived macrophages (MDMs) were generated from PBMCs, as described elsewhere [15] . Briefly, the monocytes were seeded into the 24-well plates and cultured for 14 days to differentiate into macrophages. The purity of monocytes, as determined by flow cytometry with anti-CD14 mAb, was consistently >90%.
fluA Viruses
As described in a previous study [15] , human seasonal fluA virus H1N1 (A/Hong Kong/54/98) and avian H9N2 (A/Quail/ HK/G1/97), avian H5N1 (A/HK/483/97) were cultured in Madin-Darby canine kidney cells (American Type Culture Collection). Pandemic H1N1 (A/California/04/2009, pdmH1N1) was propagated in embryonated chicken eggs. The viruses were concentrated and purified over a sucrose step gradient, as described elsewhere [16] . The virus titer was determined by daily observation of cytopathic effect, and 50% median tissue culture infective dose was calculated according to the Reed-Muench formula. MDMs were infected with the above fluA virus at a multiplicity of infection of 2. After 1 hour, the unadsorbed virus was washed away.
Flow Cytometry
Cells were stained for surface markers with the following mAbs: anti-Vδ2 (B6), anti-CD3 (HIT3a), anti-CD16 (3G8), anti-CD27 (O323), anti-CD56 (HCD56), anti-CD69 (FN50), and anti-FasL (NOK-1) (Biolegend), and anti-CD27 (M-T271), anti-CD45RA (HI100), anti-CD62L (DREG-56), anti-CD107a (H4A3), and anti-NKG2D (1D11) (BD Biosciences). Intracellular staining was performed after cell fixation and permeabilization, as described elsewhere [17] [18] [19] , and the following mAbs were used: anti-IFN-γ (25723.11; BD Biosciences) and anti-perforin (dG9) and anti-granzyme B (GB11) antibodies (Biolegend). All samples were acquired on BD FACSAria (BD Biosciences) and analyzed using Flowjo software version 8.8.6 (Tree Star).
After culture for 14 days, different γδ T-cell subsets were sorted with FACSAria-II (BD) dependent on the surface expression levels of CD27 or CD56. The isolated γδ T-cell subsets were routinely >97% pure by flow cytometric analysis.
Cytotoxicity Assay and Relevant Blocking Assay
The cytotoxicity assay of expanded γδ cells was performed with allophycocyanin-conjugated anti-CD3 mAb and EthD-2, as described elsewhere [12, 13] . In brief, MDMs (target) infected with fluA virus were cocultured with autologous IPP-expanded Vγ9Vδ2 T cells (effector) at different effector-to-target (E/T) ratios for 4-6 hours. Afterward, nonadherent cells were harvested directly. Adherent cells were detached with 0.25% (wt/vol) trypsin-0.53 mmol/L ethylenediaminetetraacetic acid. All cells were then stained with anti-CD3 to identify γδ T cells and EthD-2 to identify dead cells [20] . The cytotoxicity of γδ T cells against virus-infected MDMs was assessed by flow cytometry as the percentage of EthD-2 + cells in the CD3 − population.
For cytotoxicity blocking assays, γδ T cells (effector) were pretreated with anti-CD16 (10 µg/mL; 3G8, Biolegend) neutralization antibody or its isotype control mouse immunoglobulin G1 (IgG1) (10 µg/mL; Biolegend) for 30 minutes. These γδ T cells were then cocultured with virus-infected MDMs (target) at an E/T ratio of 10:1 for 6 hours. Cytotoxicity was analyzed by flow cytometry, as described above.
Statistical Analysis
Data were expressed as means ± standard errors of the mean. Statistical significance was determined by paired Student t test, using GraphPad Prism version 5 software. Differences were considered significant at P < .05.
RESULTS
Comparable IFN-γ Response and Cytotoxic Activity Between CD27
+ and CD27 − γδ T-Cell Subsets to fluA Viruses
We first examined whether peripheral resting Vγ9Vδ2 T cells differentiated toward different memory phenotypes after IPP expansion. As shown in Figure 1A , about 80% of peripheral resting γδ T cells showed memory phenotypes, evidenced by the loss of CD45RA. In contrast, the majority (>95%) of IPPexpanded Vγ9Vδ2 T cells were CD45RA − , composed of central + and CD27 − Vγ9Vδ2 T-cell subsets from IPP-expanded PBMCs. Abbreviation: TCR, T cell receptor. The purity of sorted cells was consistently above 97%. E, Human H1N1 virus-infected MDMs (target) were cocultured with purified autologous CD27 + and CD27 − γδ T cells (effector) at indicated effector-to-target (E/T) ratios for 6 hours. Cytotoxicity was analyzed by flow cytometry and calculated as % dead MDMs. Data shown are means ± SEMs from 4 experiments.
CD27
− , expressed few lymph node homing markers, CCR7 and CD62L ( Figure 1A ). These results indicate that on IPP/IL-2 expansion, human peripheral Vγ9Vδ2 T cells tend to differentiate into memory phenotypes.
We then examined the IFN-γ response in CD27 + and CD27 To further compare the cytotoxic capacity of CD27 + and CD27 − Vγ9Vδ2 T-cell subsets, we sorted these 2 populations by using FACSAria flow cytometry ( Figure 1D ) and determined their cytotoxic activity. As shown in Figure 1E , both CD27 + and CD27 − γδ T-cell subsets killed human seasonal The expression of CD107a (lysosome-associated membrane protein 1), a marker for exocytosis of granules, was also assessed. As shown in Figure 2C , the coculture of purified Vγ9Vδ2 T cells with H1N1-infected MDMs for 4 hours resulted in a significant increase in CD107a expression in CD56 + Vγ9Vδ2 T cells compared with that in CD56 − cells.
Similar results were also observed in these subsets upon H9N2 virus stimulation ( Figure 2C ). These data indicate that the 
Phenotypes of CD56 + and CD56 − γδ T-Cell Subsets
Our previous study showed that the cytotoxicity of human Vγ9Vδ2 T cells is dependent on the NKG2D activation and is mediated by Fas/Fas ligand (FasL) and perforin-granzyme B pathways [12] . Consequently, we further compared the levels of surface NKG2D and FasL expressions with the intracellular expression of cytotoxic granules for the CD56 + and CD56 − Vγ9Vδ2 T-cell subsets. As shown in Figure 4A , CD56 + and CD56 − γδ T-cell subsets expressed similar levels of NKG2D, perforin, granzyme B, and FasL, as well as CD69, which is a recent activation marker. Interestingly, CD56 + Vγ9Vδ2 T cells expressed a significantly higher level of CD16 than did the + and CD56 − Vγ9Vδ2 T-cell subsets were shown in representative histogram plots and statistic figure with means ± standard errors of the mean (n = 4). Gray histograms depict relevant isotype controls. The 2-tailed paired Student t test was used for comparisons; *P < .05.
CD56
− counterparts ( Figure 4B ). Because CD16 is thought to be involved in the degranulation of NK cells [24, 25] , these data suggest that this higher expression of CD16 in the CD56 + Vγ9Vδ2 T-cell subset may contribute to their superior cytotoxicity against fluA virus-infected cells.
Contribution of CD16 to Superior Cytotoxicity of CD56 + γδ
T Cells Against fluA Virus-Infected MDMs
To determine whether the cytotoxic difference between CD56 + and CD56 − Vγ9Vδ2 T-cell subsets was due to the difference in CD16 expression in these cells, CD56 + Vγ9Vδ2
T cells pretreated with the CD16 neutralization mAb were cultured with fluA virus-infected MDMs. For H1N1-infected MDMs, the blockade of CD16 significantly decreased the killing activity of CD56 + Vγ9Vδ2 T cells to the level of their CD56 − counterparts ( Figure 5A ). In contrast, the blockade of CD16 had no such blocking effect on the cytotoxicity of CD56 − cells against H1N1-infected MDMs. Similar results were also observed during the killing of H9N2-infected MDMs by these cells ( Figure 5B ). CD16 is usually associated in antibody-dependent cell-mediated cytotoxicity (ADCC) [26] ; therefore, we further sought to examine whether ADCC was involved in the cytotoxicity of CD56 + Vγ9Vδ2 T cells. As shown in Figure 5C and 5D, CD56 + Vγ9Vδ2 T cells exerted similar cytotoxicity against fluA virus-infected targets, whether they were IgG antibody coated (with AB serum) or not (without AB serum). These results suggest that the supposed serum IgG-mediated ADCC has a negligible effect on the cytotoxicity of CD56 + Vγ9Vδ2 T cells here. Collectively, these results suggest that the CD16-dependent pathway, not ADCC, is responsible for the superior cytotoxicity of CD56 + Vγ9Vδ2 T cells against fluA virus-infected MDMs.
DISCUSSION
Previously we demonstrated that phosphoantigen-expanded human γδ T cells have potent cytotoxicity against fluA virusinfected cells and exhibit type 1 cytokine responses to fluA viruses in vitro [12, 13] . More recently, we found that both the adoptive transfer of phosphoantigen-expanded Vγ9Vδ2 T cells and the use of phosphoantigen to expand Vγ9Vδ2 T cells in vivo can control fluA pathogenesis in a humanized mouse model [14] , suggesting γδ T cell-based immunotherapy has a great potential for treating fluA infection. In the current study, we demonstrated for the first time that CD56 + Vγ9Vδ2 T cells are the more potent anti-influenza cytolytic subset compared with their CD56 − counterparts, although their IFN-γ productions are at similar levels. We also showed that central memory (CD45RA It is believed that central memory αβ T cells have a greater ability of expansion, whereas effector memory αβ T cells display faster and more potent effector functions [27] . Recent studies suggest that γδ T cells also have central and effector memory subsets. In the mouse model, it has been found that CD27 + γδ TCR thymocytes had much stronger IFN-γ response to PMA and ionomycin stimulation than their CD27 − counterparts [7] . On the contrary, the circulating + and CD56 − Vγ9Vδ2 T cells (effector) were pretreated with anti-CD16 (αCD16, 10 μg/mL) blocking antibody or its isotype control mouse immunoglobulin G1 (mIgG1) (10 μg/mL) for 30 minutes. These Vγ9Vδ2 T cells were then cocultured with H1N1 (A) or H9N2 (B) virus-infected MDMs (target) at an effector-to-target (E/T) ratio of 10:1 for 6 hours. C, D, Purified CD56 + γδ T cells (effector) were cocultured with H1N1 (C) or H9N2 (D) virus-infected MDMs (target) at an E/T ratio of 10:1 for 6 hours, with or without human AB serum in medium. Cytotoxicity was analyzed by flow cytometry and calculated as % dead MDMs. Data shown are means ± standard errors of the mean from 4 experiments. The 2-tailed paired Student t tests was used for comparisons; *P < .05.
Several recent reports suggest that CD56 expression may be associated with differentiated cytolytic effector function not only in conventional αβ T cells but also in γδ T cells [21, 22, 28, 29] T cells exhibited stronger cytotoxic activity against several solid tumor cells than their CD56 − counterparts [28] .
Although CD56 acts as an adhesion molecule in NK-target cell interaction [30] and cross-linking of CD56 induces cell signaling [31] in some contexts, the direct correlation between this molecule and cell-mediated cytotoxicity has not been established [31] . In our previous study, we found that the cytotoxicity of γδ T cells against fluA virus-infected cells is dependent on NKG2D activation and mediated by Fas/FasL and perforin-granzyme B pathways [12] . However, we did not observe a significant difference in the expression levels of NKG2D, perforin, granzyme B, FasL, and CD69 between CD56 + and CD56 − Vγ9Vδ2 T-cell subsets, suggesting that these activation and cytotoxicity-related pathways may not contribute to the superior killing ability of CD56 + γδ T cells against fluA virus-infected cells. Interestingly, we found that CD56 + γδ T cells expressed significantly higher levels of CD16 compared with their CD56 − counterparts. Furthermore, we demonstrated that CD16 contributed to the superior killing activity of CD56 + γδ T cells, compared with their CD56 − counterparts, against virusinfected MDMs. Indeed, it is thought that CD16 participates in the cell-mediated cytotoxicity of NK, αβ T cells, and even γδ T cells through 3 main pathways: (1) ADCC [26, 32] , (2) the CD16-mediated degranulation pathway [24, 25] , and (3) acting as a lysis receptor that mediates the killing of some virus-infected and tumor cells independent of antibody ligation [33] . Recently, it has been reported that phosphoantigens could enhance the ADCC function of γδ T cells against tumor cells [34] . However, we demonstrate here that the cytotoxicity of CD56 + γδ T cells against fluA virus-infected cells was not dependent on serum IgG-mediated ADCC. Combined with the evidence that the superior cytotoxicity of CD56 + Vγ9Vδ2
T cells is also associated with higher expression of CD107a, a degranulation marker, our findings indicate that CD16 may be involved in the degranulation pathway of γδ T cells instead of the ADCC pathway, leading to the difference in cytotoxicity of the 2 subsets.
In summary, we found that IPP-expanded CD56 + Vγ9Vδ2
T cells had higher cytotoxicity against virus-infected cells than their CD56 − counterparts, although these 2 subsets had similar IFN-γ responses to fluA viruses. Moreover, the CD16-dependent degranulation pathway contributed to the superior cytotoxicity of the CD56 + γδ T-cell subset. We also showed that both central (CD45RA Potential conflicts of interest. All authors: No reported conflicts.
